<DOC>
	<DOC>NCT01886781</DOC>
	<brief_summary>In patients with IBS, will supplementation with a probiotic demonstrate symptomatic efficacy and will the probiotic influence gut microflora and thus improve clinical outcomes, as compared to no intervention.</brief_summary>
	<brief_title>Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome</brief_title>
	<detailed_description>Conduct a study on nutrient intakes gastrointestinal microbiota and the effect of a probiotic, Lactobacillus plantarum 299v in irritable bowel syndrome patients.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<criteria>fulfillment of the Rome II criteria for IBS, availability of at least one colonoscopy within the last three years, aged 18 or older at the time of screening, provision of written informed consent, commitment of availability throughout the 12 week study period. major abdominal surgery in the past other than other than appendectomy, caesarean section, tubal laparoscopic cholecystectomy, abdominal wall hernia repair or/and hysterectomy, current use of antibiotics, history of organic intestinal disease, pregnant or breastfeeding mothers, chronic infectious disease like HIV or tuberculosis, and unable to understand English or Afrikaans.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>only constipation and diarrhea predominant</keyword>
	<keyword>no mixed or alternating types</keyword>
</DOC>